Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors and treatment strategies for cholecystitis after metallic stent placement for malignant biliary obstruction: a multicenter retrospective study.
Matsumi A, Kato H, Ogawa T, Ueki T, Wato M, Fujii M, Toyokawa T, Harada R, Ishihara Y, Takatani M, Tsugeno H, Yunoki N, Tomoda T, Mitsuhashi T, Otsuka M. Matsumi A, et al. Among authors: ishihara y. Gastrointest Endosc. 2024 Mar 13:S0016-5107(24)00133-0. doi: 10.1016/j.gie.2024.02.019. Online ahead of print. Gastrointest Endosc. 2024. PMID: 38490459
Treatment outcomes, including risk factors of stone recurrence, for hepatolithiasis using balloon-assisted endoscopy in patients with hepaticojejunostomy (with video).
Ishihara Y, Matsumoto K, Kato H, Tsutsumi K, Tomoda T, Matsumi A, Miyamoto K, Yamazaki T, Saragai Y, Fujii Y, Uchida D, Horiguchi S, Okada H. Ishihara Y, et al. Surg Endosc. 2021 Apr;35(4):1895-1902. doi: 10.1007/s00464-020-08139-6. Epub 2020 Nov 2. Surg Endosc. 2021. PMID: 33140150 Free article.
Bilateral verses bilateral with tri-segmental endoscopic drainage using metal stents for high-grade malignant hilar biliary obstructions: A multicenter, randomized controlled trial: BRAVE study (BRAVE study).
Matsumoto K, Mitsuhashi T, Kawamoto H, Ishida E, Fujii M, Akimoto Y, Seki H, Ishihara Y, Ogawa T, Yamazaki T, Fujii Y, Kato H. Matsumoto K, et al. Among authors: ishihara y. Medicine (Baltimore). 2022 Oct 7;101(40):e30857. doi: 10.1097/MD.0000000000030857. Medicine (Baltimore). 2022. PMID: 36221399 Free PMC article. Clinical Trial.
Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding.
Terasawa H, Matsumoto K, Tanaka T, Tomoda T, Ogawa T, Ishihara Y, Kikuchi T, Obata T, Oda T, Matsumi A, Miyamoto K, Morimoto K, Fujii Y, Yamazaki T, Uchida D, Horiguchi S, Tsutsumi K, Kato H, Otsuka M. Terasawa H, et al. Among authors: ishihara y. Pancreatology. 2023 Dec;23(8):988-995. doi: 10.1016/j.pan.2023.10.018. Epub 2023 Oct 28. Pancreatology. 2023. PMID: 37951728
The role of the methoxy group in approved drugs.
Chiodi D, Ishihara Y. Chiodi D, et al. Among authors: ishihara y. Eur J Med Chem. 2024 Apr 4;273:116364. doi: 10.1016/j.ejmech.2024.116364. Online ahead of print. Eur J Med Chem. 2024. PMID: 38781921 Review.
Characteristic craniofacial defects associated with a novel USP9X truncation mutation.
Nagata N, Kurosaka H, Higashi K, Yamaguchi M, Yamamoto S, Inubushi T, Nagata M, Ishihara Y, Yonei A, Miyashita Y, Asano Y, Sakai N, Sakata Y, Kawabata S, Yamashiro T. Nagata N, et al. Among authors: ishihara y. Hum Genome Var. 2024 May 16;11(1):21. doi: 10.1038/s41439-024-00277-w. Hum Genome Var. 2024. PMID: 38755172 Free PMC article.
1,143 results